Login / Signup

Radiosensitization of Allogenic Subcutaneous C6 Glioma Model with Focused Ultrasound-Induced Mild Hyperthermia.

Zhiyuan XuDavid SchlesingerRobert Andrew DrainvilleDavid MoorePatcharin PramoonjagoJason SheehanFrederic Padilla
Published in: Life (Basel, Switzerland) (2024)
The radiosensitization potential of focused ultrasound (FUS)-induced mild hyperthermia was assessed in an allogenic subcutaneous C6 glioma tumor model in rats. Mild hyperthermia at 42 °C was induced in tumors using a single-element 350 kHz FUS transducer. Radiation was delivered with a small animal radiation research platform using a single-beam irradiation technique. The combined treatment involved 20 min of FUS hyperthermia immediately before radiation. Tumor growth changes were observed one week post-treatment. A radiation dose of 2 Gy alone showed limited tumor control (30% reduction). However, when combined with FUS hyperthermia, there was a significant reduction in tumor growth compared to other treatments (tumor volumes: control-1174 ± 554 mm 3 , FUS-HT-1483 ± 702 mm 3 , 2 Gy-609 ± 300 mm 3 , FUS-HT + 2 Gy-259 ± 186 mm 3 ; ANOVA p < 0.00001). Immunohistological analysis suggested increased DNA damage as a short-term mechanism for tumor control in the combined treatment. In conclusion, FUS-induced mild hyperthermia can enhance the effectiveness of radiation in a glioma tumor model, potentially improving the outcome of standard radiation treatments for better tumor control.
Keyphrases
  • high glucose
  • dna damage
  • diabetic rats
  • randomized controlled trial
  • drug induced
  • systematic review
  • radiation induced
  • radiation therapy
  • combination therapy
  • climate change
  • single cell